AmerisourceBergen acquired IntrinsiQ
The acquisition allows IntrinsiQ to become a part of ION Solutions, a unit of AmerisourceBergen Specialty Group. The combination of IntrinsiQ’s software applications and ION Solutions’ oncology technology
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.